Kardigan

📍 Princeton, United States🗓 Founded 2023👥 183 employees💰 Last funded May 2026
Biotechnology Research🌐 kardigan.bio
Website LinkedIn
Kardigan is a patient-driven heart health company that is modernizing cardiovascular drug development to deliver medicines that move patients beyond symptom management to functional cures. By matching critical disease drivers with treatment responders identified in clinical trials, Kardigan is developing a portfolio of medicines that modify the underlying cardiovascular disease pathophysiology to get patients closer to the cures they deserve. Kardigan has significant East and West Coast operations and focus. For more information about Kardigan, please visit kardigan.bio. If you are interested in joining our passionate and driven team with deep cardiovascular, biotechnology and operational expertise, please visit kardigan.bio or the careers tab of this page.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2023
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Kardigan?
Kardigan has 1 investors on record on gritt.io, 1 mid-stage.
When did Kardigan last raise funding?
The most recent investment in Kardigan recorded on gritt.io was in May 2026.
When was Kardigan founded?
Kardigan was founded in 2023.
What industry is Kardigan in?
Kardigan operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Kardigan based?
Kardigan is headquartered in Princeton, United States.